Fluorescent Nanoparticles to Identify and Kill Cancer Cells

New nanomedicine platform helps visualize tumor and kills remaining tumor cells that cannot be surgically removed.

A nanomedicine platform which helps doctors know which cancer tissue to cut out as well as kill any malignant cells that can't be surgically removed, has been developed by a research team at Oregon State University.

The platform allows for greater precision and thoroughness in cancer treatment.

Destroying Viruses Using Gold Nanoparticles
Revolutionary approach uses nanoparticles to attract viruses and using the resulting pressure from the binding process, destroy them.

‘Fluorescent nanoparticles allow cancer visualization and allows doctors to surgically remove tumor regions and also self-destroys cells that cannot be surgically removed.’

Here's how it works:

Nanoparticles tightly loaded with a dye compound are administered systemically - injected intravenously or into the peritoneum, the abdominal cavity. When they reach the tumor site, the tumor's intracellular environment effectively flips the switch on the compound's fluorescence.

That enables detection by a near infrared (NIR) imaging system that helps surgeons know in real time what needs to be removed.

Nanoparticles may Effectively Treat Antibiotic Resistance
Scientists have succeeded in developing an effective method to treat cystic fibrosis with nanoparticles that transport the antibiotics.

Any glowing areas that can't be cut out are given phototherapy - irradiated with a near infrared laser, which causes the nanoparticles to heat up and kill the residual cancer cells.

The findings by researchers in the OSU/OHSU College of Pharmacy and OSU College of Veterinary Medicine were published in Theranostics.

Drug-delivering Nanoparticles Can Destroy Cancer Stem Cells
Niclosamide-bearing targeted nanoparticles help prevent the growth of breast cancer stem cells and also reduce recurrence of cancer.

The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially - until the tumor activates the fluorescence by loosening the packing - it doesn't cause any non-cancerous tissue to glow.

Corresponding authors Olena Taratula and Oleh Taratula of the Department of Pharmaceutical Sciences and their collaborators evaluated the platform in vitro and in two different mouse models, including one that mimicked ovarian intraperitoneal metastasis.

Multifunctional Nanoparticles Show Promise for Cancer Surgery
Engineered naphthalocyanine-based nanoparticles (SiNc-PNP), light up during surgery when they connect with the cancerous tumors.

The research team operated on the mice using real-time imaging, which showed that the new nanoparticles are compatible with a standard, FDA-approved imaging system. The efficacy of the phototherapy was also demonstrated in vivo.

"The nanoplatform system is quite simple but quite effective," Olena Taratula said.

Subsequent laboratory testing of the platform will include rats, she said, followed by testing on dogs that are already scheduled for cancer surgeries at the College of Veterinary Medicine.

"They're going to do surgery on those dogs anyway, and they can use our nanomedicine platform as an additional tool to see if they can identify the cancer cells," Taratula said.

Source-Eurekalert